Table 1. Clinical data of MS and control autopsies included in the study.
| Patientno. | Age (years) | Sex | Samples* | Disease |
| 1 | 52 | F | CWM-1/ CGM-1 | Myocardial infraction |
| 2 | 53 | F | CWM-2/ CGM-2 | Cardiac thrombosis |
| 3 | 77 | M | CWM-3/ CGM-3 | Mesenteric bleeding |
| 4 | 46 | M | NAWM-1/ WML-1 | Secondary progressive MS |
| 5 | 51 | F | NAWM-2/ WML-2 | Secondary progressive MS |
| 6 | 63 | F | NAWM-3/ WML-3 | Secondary progressive MS |
| 7 | 53 | F | NAGM-1/GML-1 | Secondary progressive MS |
| 8 | 52 | M | NAGM-2/GML-2 | Secondary progressive MS |
| 9 | 52 | M | NAGM-3/GML-3 | Secondary progressive MS |
*
CWM: Control white matter; CGM: Control gray matter; NAWM: Normal appearing white matter; WML: White matter lesioned; NAGM: Normal appearing gray matter; GML: Gray matter lesioned.